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Abstract  
                  Biofilms are now considered ubiquitous in the natural world. Bacterial biofilms have 
been observed to be extremely heterogeneous, both structurally and with regard to the 
physiology of the bacterial cells within them. The prevailing conceptual model depicts bacterial 
biofilms as being made up of microcolonies, which serve as the basic unit of the greater biofilm 
structure. A major concern with this approach is the frequently observed development of 
resistance to antimicrobial compounds. A number of elements in the process of biofilm 
formation have been studied as targets for novel drug delivery technologies. The present study 
aimed to penetrate  biofilm by  gram positive and gram negative bacteria by in-vitro culture 
technique, with developed nano emulsion containing photodynamic agents. The results of this 
study are encouraged  and significantly prevent the formation of microcolonies, building bocks 
of biofilms. 
 
 
 
 
 
 
 
Introduction    
             Bio-films are defined as collection of organisms ( microcolonies) which are attached to a 
surface by a matrix. This matrix is called as Extracellular Polymeric Substances (EPS). It has 
good protection against macrophages and antibiotics which allows surviving even in hostile 
environment. Due to their resistant phenotype it is difficult to eradicate. Attaching to the wet 
surface is the natural tendency of microbes and after attaching they manufacture a protective 
carbohydrate matrix which allows to attach to each other and to host wound surface3. Bio films 
are found in Chronic wounds9. There are number of mechanisms by which various microbial 
species are able to attach to a surface and promote cell-cell interactions and grow as a complex 
structures called biofilms. 
            Formation of Biofilm occurs in a sequence of steps . They are  Attachment of  bacteria to 
a solid surface, Proliferation and accumulation in multilayer cell cluster, Formation of bacterial 
community enclosed in a self-produced polymeric matrix5. Attachment of microorganisms to 
surface and biofilm development are very complex processes and affected by several variables. 
Generally attachment occurs on surfaces that are rough , more hydrophobic and coated surface 
conditioning film. Cell surface property, particularly the presence of extra cellular appendages , 
the interaction involved in cell-cell communication and EPS production are important for the 
formation and development of biofilm7. Hydrophobicity of cell surface is important in adhesion 
as hydrophobic interaction tends to increase with an increasing non-polar nature of one or both 
surfaces involved.  
           
           Extracellular Polymeric Substances  is responsible for binding cells and other particulate 
material together and to the surface. EPS composes of polysaccharides , proteins , nucleic acids , 
lipids , phospholipids and humic substances. Proteins and phospholipids are the major 
components of EPS . EPS acts as barrier and tolerate high amount of biocides and also delays or 
prevents antimicrobials reaching target microorganisms by diffusion limitation6. Lipids and 
nucleic acids influence the rheological properties and the stability of the biofilm significantly. 
Extracellular DNA  required for initial establishment of biofilm. Cell-Cell communication is a 
driving force for self-organization and co-operation among the cells. These signals governors 
cell attachment and detachment , facilitates their adaption to change in environment . They 
respond to external environment and modulate their gene expression accordingly. Bacteria 
produce diffusible organic signals called auto inducer (AI) molecules which accumulate in 
surrounding environment. Their functions are extracellular enzymes biosynthesis, biofilm 
development, antibiotic biosynthesis, bio surfactant production and EPS synthesis.             
           There are different methods in treating biofilm on wound , they are differentiated in to 
mechanical debridement and chemical debridement. Mechanical Debriement  is to completely 
removing all necrotic tissues and biofilm in the wound bed while leaving tissues untouched. 
Hydro surgery7 can be used in which debridement of wound tissue is done by both cutting and 
aspirating the necrotic soft tissue. Wound dressing can also be done to remove the moisture 
content in wound. Commercial antimicrobial and topical enzymatic agents used in wound care 
cannot penetrate into biofilm and cannot eliminate critical wound bacterial colonization and 
stimulate wound healing. Chemical Debridement  is using of agents like silver and bleach 
containing compounds and antibiotic can provide bactericidal effect with biofilm. Silver coating 
cam also be done to prevent biofilm formation on industrial equipment. Ionic silver has a effect 
in wound care due to interference with the transport system of biofilm.  
              But the above mentioned techniques helps in treatment of biofilms only to an extent and 
they cannot prevent the reoccurrence of the bacterial biofilms . The use of non-invasive 
Photodynamic Antimicrobial Chemotherapy (PACT) can overcome most of the problems which 
are associated with the biofilms. The principle of PACT is the same as the traditional 
photodynamic therapy . this is a non-intrusive technique that uses a combination of light and 
non-toxic drug (photosensitizer) to destroy targeted cells. The inactive drug is activated by 
irradiation at certain wave length producing reactive oxygen species , which destroys the targeted 
cells without causing much damage to healthy cells. Once the irradiation is stopped the 
photosensitive drug gets back into its intial inactive form. The main limitation of photodynamic 
therapy is the uptake kinetics of the inactive drug by the micro organisms. Neutral , cationic and 
anionic photosensitizers are effective on gram positive bacteria19 and where as hydrophilic 
cationic photosensitizers are effective on gram negative bacteria. Gram negative bacteria are 
more resistant because of their cell envelope and the outer membrane which provides very good 
protection against environment and antibiotics. Nano emulsion studies are found to be efficient 
in biological applications  which have good efficacy in solubilization and targeted drug 
delivery15-17. In the present study we formulated different formulations of nano emulsions and we 
have grown biofilm in  invitro conditions and successfully tested the formulations on the 
biofilms. 
 
 
 Experimental Methods and Procedures  
 
The biofilm of E coli (Gram negative) are successfully grown using CDC Bio-Reactor.  
• Bio-reactor is a one liter vessel with an effluent spout at approximately 400 ml. 
• A 5 gallons of  diluted broth is made to run through the bio reactor continuously for 24 to 
72 hrs till the formation of bio film. 
•  Continuous mixing of the reactor’s bulk fluid is provided by a baffled stir bar that is 
magnetically driven.  
• An UHMW polyethylene top supports eight independent rods. Each rod houses three 
removable coupons (biofilm growth surfaces) for a total of 24 sampling opportunities. 
•  The bioreactor operates as a continuous flow stirred tank reactor, as such nutrients are 
continuously pumped into and flow out of the reactor, leaving only biofilm.  
• The bioreactor provides opportunity for checking the samples periodically . The bio film 
growth can be checked from 24 hrs from the starting time and for every hour . 
• The samples also can collected periodically depending on the experimental conditions . 
• The used broth can also be collected and disposed off safely without any kind of 
contamination. 
 
 
 
                                                                                                                                              
Preparation of Nanoemulsion Formulations 
             The nanoemulsion drug is being prepared for optimal drug delivery. We have chosen 
hydrophobic photosensitizers which are less permeable to cross the cell barrier. Many studies 
have shown that using nanoemulsions as carriers for biomedical applications can improve 
efficacy in solubilizing, protecting, and targeting microorganisms for specified delivery. 
Therefore one can anticipate that our approach can greatly advance current chronic wound 
treatment. 
                In this study we have chosen copper Phthalocyanine (CuPc) and riboflavin (vitamin 
B2) as hydrophobic photosensitizers. The main reason for using this as a PACT agent is owing to 
the certainty of its non-toxic nature towards human tissue.  In order to promote the drug delivery 
oil-in-water nanoemulsion formulations have been developed. 
Preparation of oil in water (o/w) nanoemulsion 
Formulation 1 
In this formulation we use Copper phthalocyanine (CuPc) which will have a final oil phase. 
• Dissolve 5.0 mg of copper phthalocyanine (CuPc) and 2.0 mL of surfynol-465 
(surfactant, wetting agent) in 20 mL of ethyl acetate (organic phase) over low heat with constant 
stirring. 
• 2 gm of poly ethylene glycol (PEG200) is dissolved in 20 mL of water (water phase). 
• Add the organic phase into water phase drop by drop with vigorously stirring over low 
flame until all the ethyl acetate has evaporated.  
• Sonicate for 20 minutes. 
Preparation of water in oil in water (w/o/w) nanoemulsion 
•  A water-oil-water (w/o/w) double emulsion method is developed to entrap hydrophilic 
vitamin riboflavin inside the double coated nanoparticles.  
Formulation 2 
• In this formulation we use riboflavin (vitamin B2), as photosensitizer. 
• First 30 mg of riboflavin and 2.0g  poly ethylene glycol (PEG 200) is dissolved in 20 mL 
of water (water phase). 
• Dissolve 20 mL of castor oil and 2.0mL of surfynol-465 (organic phase) over low heat 
with constant stirring. 
• The water phase is added drop by drop into the organic phase with constant stirring, 
reverse micelles are formed in this step (w/o emulsion). 
• The final water phase is prepared by dissolving 2.0mL of polysorbate80 (surfactant) in 20 
mL of water. 
• Finally, the w/o emulsion from above is added drop by drop into the final water phase 
with constant stirring. 
• Keep stirring until all the water is evaporated, a double emulsion is formed in this step. 
• Surfynol-PEG is good pair of hydrophobic-hydrophilic double emulsion. 
 
 
Formulation 3 
• In this formulation we use riboflavin (vitamin B2), nanoparticles. 
• First 30 mg of riboflavin and 2.0g  poly ethylene glycol (PEG 200) is dissolved in 20 mL 
of water (water phase). 
• Dissolve 20 mL of castor oil and 2.0mL of surfynol-465 (organic phase) over low heat 
with constant stirring. 
• The water phase is added drop by drop into the organic phase with constant stirring, 
reverse micelles are formed in this step (w/o emulsion). 
• The final water phase is prepared by dissolving 2.0mL of poloxamer-407 in 20 mL of 
water. 
• Finally, the w/o emulsion from above is added drop by drop into the final water phase 
with constant stirring. 
• Keep stirring until all the water is evaporated, a double emulsion is formed in this step. 
• Surfynol-PEG and Surfynol-Poloxamer-407 are all good pairs for a hydrophobic-
hydrophilic double emulsion. 
           The grown biofilm coupons are removed and drop each emulsion formulations on the top 
of the coupon and each coupon is placed  in a test tube containing TSB.                                 
           
           Half of the  test tubes are kept in dark (that means covering the test tube with aluminum 
foil to prevent exposure to light) and the other half are incubated for 30 minutes at 35˚C and then 
irradiated to light for 30 minutes. The test tubes that are kept in dark and irradiated  to light are 
incubated for 24 hours. 
            Serial dilution is made 9x times with each test tube for counting of the bacteria .Four test 
tubes, each with 9 mL of sterile tryptic soy broth, and labelled from 1to4. Then 1 mL sample is 
taken from the bacterial suspension(test tube with coupon)  that we wish to count and add it to 
the first tube.  Mix well, this is 1:10 dilution ratio because we have added 1 mL to 10mL total. 
Then 1mLof dilution broth suspension is removed from tube 1 and added to tube 2. Mix well, 
this dilution and each following mix increasingly will be diluted by a factor of 10. Thus, tube 2 is 
1:100 dilutions. Then 1mLof dilution broth suspension is removed from tube 2 and added to tube 
3 and mixed  well. The same dilutions are followed for all the test tubes.  Then 1mLof dilution 
broth suspension is taken from tube 4 and added it to the surface of sterile nutrient medium in a 
Petri dish. Spread evenly and incubate the plates upsides down allow the bacteria to multiply for 
24 to 48 hours at 37˚C. 
 
 
 
 
 
 
 
 
 
Results & Discussion  
The Petri plate after incubating to 24 to 48 hours, the bacterial colonies that grew on the plates 
are counted.  
Formulation 1  
       We have seen that for formulation 1(copper phalocyanin)  the bacterial cell count for the 
Petri plates that has sample from test tubes kept in  dark are 92 cells and for the Petri plates that 
have samples from test tubes kept in light have no growth i.e 0 cells. Thus the percentage of 
bacteria that are killed is calculated as the number of colonies on the plate times the reciprocal of 
dilution factor gives the percentage of killing the microorganisms. 
Therefore the formulation 1 has killed all the bacteria , almost 100%.  
Formulation 2 
          We have seen that for formulation 2 (Riboflavin with polysorbate80 as surfactant) the 
bacterial cell count for the Petri plates that have sample from test tubes kept in dark have 147 
cells and for the Petri plates that have samples from test tubes kept in light have 0 cells. 
Therefore we can say that the formulation 2 also have prevented the growth of bacteria upto 
100%  
Formulation 3 
        We have seen that for formulation 3 (riboflavin with poloxamer-407 as surfactant) the 
bacterial cell count for the Petri plates that have saples from test tubes kept in  dark have 897 
cells and for the Petri plates that have samples from test tubes kept in light have 142cells.  The 
percentage of bacteria that is killed is calculated and the percentage of the prevention of growing 
of bacteria is  84.2% . 
 
Figure1                                                                                                        
The following figures are the Petri plates which are after incubation to 37˚C. 
 
 
 
 Figure 2 : SEM Images of biofilm 
 
 
 
 
            
           The results shows that  concentration   of 5.0 mg of copper pthalocyanin can kill 100% of 
bacteria after incubation followed by 0.5 h of irradiation with low intensity light, ~5.0 J/cm2 and 
a concentration of 30 mg Riboflavin with polysorbate 80 as a surfactant can kill 100% of 
bacteria, where as the concentration of 30mg Riboflavin with poloxamer-407 as a surfactant can 
kill only 84.2% . This condition in using riboflavin is due to the less penetration of the drug with 
poloxamer-407 as a surfactant. Hereby we can say that   the nanoemulsions formulated  can 
easily pass through the bacterial membrane releasing  the photosensitizers which when activated 
producing reactive oxygen species killing the bacteria inside the biofilm. 
Table 1 : Results of formulations used on biofilm coupons kept in light and dark 
 
 
 Formulation 1                  
(copper pthalocyanin) 
Formulation 2 
(Riboflavin with 
polysorbate80) 
Formulation3 
(Riboflavin with 
poloxamer-407) 
Concentration 0.001 0.03 0.03 
Dark 92 cells 147 cells 142 cells 
Light 0 cells 0 cells 897 cells 
%  Kills 100% 100% 84.2% 
Conclusion 
                From the above results we can assume that  photodynamic antimicrobial chemotherapy 
(PACT) has the potential to represent an alternative antibacterial  treatment for drug-resistant 
organisms. PDT uses normal visible light and nontoxic vitamin photosensitizer to destroy 
specific targeted cells. Nano emulsions, that we formulated   are   very much effective in  drug 
delivery across the biofilms. We have developed a   nanoemulsion in such a way  to increase the 
solubility of these drugs which are  otherwise hard to dissolve hydrophobic vitamins for the 
faster and  more effective delivery to the targeted cells. Therefore  the experimental procedure 
and results  provides a photodynamic chemotherapeutic regime for the treatment of chronic 
wound ulcers by microbial biofilm. 
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